Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

FTSE 100

(UKX)
Delayed Great Britain  -  11:35 2022-12-02 am EST
7556.23 PTS   -0.03%
After hours
 0.00%
7556.23 PTS
12/02Weekly market update : One step forward, one step back
MS
12/02FTSE 100 Index Ends the Week 0.93% Higher at 7556.23 -- Data Talk
DJ
12/02Plunging Eurozone Industrial Producer Prices Push European Equities Lower
MT
SummaryQuotesChartsNewsHeatmapComponents 
SummaryMost relevantAll NewsOther languagesNews of the index componentsMarketScreener Strategies
News of the index components FTSE 100
12/02Northrop Grumman unveils B-21 nuclear bomber for U.S. Air Force
RE
12/02Unilever: Ben & Jerry's has no power to sue over Israeli ice cream sale
RE
12/02Associated British Foods : Responsible Sourcing
PU
12/02Shell Gets Nigerian Supreme Court Nod to Appeal $1.8 Billion Compensation Order
MT
12/02Transaction in Own Shares
GL
12/02Relx : Transactions in own shares - Form 6-K
PU
12/02Nigeria's top court allows Shell to appeal order holding back assets sale
RE
12/02Oil giant BP finds new home for London headquarters
RE
12/02Reckitt expects U.S. infant formula shortage until spring
RE
12/02Smurfit Kappa Group plc Announces Retirement of Directors
CI
12/02Jemperli (dostarlimab) RUBY phase III trial met its primary endpoint in a planned inter..
AQ
12/02UK dividends calendar - next 7 days
AN
12/02UK earnings, trading statements calendar - next 7 days
AN
12/02BP Reaches Agreement with Union for Refinery in Rotterdam, Netherlands,
MT
12/02Glencore Appoints Gill Marcus as Senior Independent Director in Diversity Move
DJ
12/02IN BRIEF: Glencore makes Marcus senior director in place of Gilbert
AN
12/02Segro : Inside Information / Other news releases
PU
12/02St James Place : The cost of a comfortable retirement
PU
12/02Glencore plc Announces Board Position Changes
CI
12/02GSK Says Cancer Drug Met Primary Endpoint in Interim Analysis of Phase 3 Trial
MT
12/02Shell Gets Nigerian Top Court Approval to Appeal Oil Spill Ruling
MT
12/02Citigroup Downgrades Rio Tinto to Neutral From Buy
MT
12/02GSK Says European Medicines Agency Accepted Marketing Authorization Application for Pot..
MT
12/02Gsk : European Medicines Agency accepts marketing authorisation application for momelotini..
PU
12/02Northrop Grumman set to unveil B-21 nuclear bomber for U.S. Air Force
RE
12/02Goldman Sachs Upgrades Associated British Foods to Neutral from Sell, Boosts PT
MT
12/02ASTRAZENECA : Deutsche Bank reaffirms its Buy rating
MD
12/02Morgan Stanley Resumes Sainsbury's Coverage with Underweight Rating
MT
12/02UK insurers face watchdog crackdown for undervaluing cars while settling claims
RE
12/02Citigroup Cuts GSK PT, Keeps Neutral Rating
MT
12/02Citigroup Cuts BT Group PT, Maintains Neutral Rating
MT
12/02Deutsche Bank Keeps Kingfisher At Buy, Trims PT
MT
12/02UBS Lowers DS Smith PT, Affirms Buy Rating
MT
12/02RELX : UBS reiterates its Buy rating
MD
12/02Morgan Stanley Resumes Tesco Coverage with Equalweight Rating
MT
12/02Citigroup Downgrades Rio Tinto to Neutral from Buy, Trims PT
MT
12/02LONDON BROKER RATINGS: Jefferies raises AJ Bell to 'buy' from 'hol..
AN
12/02Norges Bank - Form 8.3 - Horizon Therapeutics Plc
PR
12/02LONDON MARKET OPEN: Stocks mixed with eyes on US data; dollar weaker
AN
12/02TOP NEWS: GSK gets EMA validation for bone marrow cancer treatment
AN
12/02Intercontinental Hotels : IHG Expands its Presence in Mainland China's Luxury Boutique Hot..
PU
12/02LONDON BRIEFING: Asos interim CFO departs; Safestore enters Germany
AN
12/02GSK Phase 3 Trial for Jemperli Endometrial Cancer Treatment Met Primary Endpoint
DJ
12/02Gsk : European Medicines Agency accepts marketing authorisation application for momelotini..
PU
12/02GSK's Endometrial Cancer Combo Improves Progression-free Survival In Late-sate Study
MT
12/02GSK Wins European Medicines Regulator's Marketing Authorization For Myelofibrosis Drug
MT
12/02BP : JP Morgan remains Neutral
MD
12/02SHELL (NEU) : Buy rating from JP Morgan
MD
12/02GSK plc Announces European Medicines Agency Accepts Marketing Authorisation Application..
CI
12/02IAG EURO : JP Morgan remains Neutral
MD
Chart FTSE 100
Duration : Period :
FTSE 100 Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FTSE 100
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Rankings
ASSOCIATED BRITISH FOODS PLC 1667.5 Delayed Quote.5.04%
ROLLS-ROYCE HOLDINGS PLC 90.25 Delayed Quote.3.82%
HARGREAVES LANSDOWN PLC 871.8 Delayed Quote.2.25%
ANTOFAGASTA PLC 1434.5 Delayed Quote.2.06%
NATWEST GROUP PLC 261.9 Delayed Quote.1.75%
ASHTEAD GROUP PLC 5012 Delayed Quote.-1.45%
MELROSE INDUSTRIES PLC 128.5 Delayed Quote.-1.53%
BP PLC 480.9 Delayed Quote.-1.75%
HARBOUR ENERGY PLC 312.6 Delayed Quote.-1.82%
INTERMEDIATE CAPITAL GROUP PLC 1243 Delayed Quote.-1.97%